Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Fuzeon (T-20) set for launch in 2003

Aug. 9, 2002

Novel anti-HIV agents presented by AIDS Care Pharma

Aug. 7, 2002

Coviracil phase III interim results

Aug. 5, 2002

Immune Network and AbNovo to develop antibody-based therapeutics for viral diseases

Aug. 1, 2002

Ampligen promising in salvage therapy and HAART/STI regimens

July 25, 2002

Maintenance of CD4 T-cell levels reported in HIV patients treated with Remune

July 25, 2002

S-1360 well tolerated in phase I

July 23, 2002

Immune Network and ViroLogic enter hNM01 research collaboration in HIV

July 23, 2002

A new carrageenan-based microbicide gel for sexually transmitted diseases

July 22, 2002

ACH-126443 enters phase II program in HIV/AIDS

July 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...